CHIEF EXECUTIVE OFFICER
Elliot Maza was appointed Chief Executive Officer of Immune Pharmaceuticals in September 2017, after serving in this capacity on an interim basis since April 2017 and as a Director since January 2015. Previously he was Chairman, Chief Executive Officer and Chief Financial Officer at Intellect Neurosciences, Inc., Chief Executive Officer and Chief Financial Officer at Biozone Pharmaceuticals, Inc. and Chief Financial Officer of Emisphere Technologies Inc. Elliot was a Partner, Transaction Advisory Services, at Ernst & Young, LLP. He began his professional career as an Attorney at Sullivan and Cromwell in New York and then in Investment banking as Vice President of Structured Finance in the Fixed Income divisions of Goldman Sachs & Co. and J.P. Morgan Securities, Inc., where he developed and marketed structured finance and derivative based transactions. Elliot has served on numerous Boards of Directors for OTC and NASDAQ traded companies, including positions as Chairman of the Audit Committee. He is a registered attorney and a licensed C.P.A. (inactive) in the states of New York and New Jersey. He received a B.A. in Accounting from Touro College in New York and a J.D. from the University of Pennsylvania Law School.